share_log

Biotricity analyst ratings

Biotricity analyst ratings

Biotricity 分析師評級
Benzinga Analyst Ratings ·  2022/07/15 06:20
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/15/2022 48.15% HC Wainwright & Co. $6 → $2 Maintains Buy
03/07/2022 270.37% Lake Street → $5 Initiates Coverage On → Buy
11/23/2021 344.44% HC Wainwright & Co. → $6 Initiates Coverage On → Buy
07/01/2021 418.52% Northland Capital Markets → $7 Initiates Coverage On → Outperform
日期 上行/下行 分析師事務所 目標價格變動 評級變動 之前/當前的評級
07/15/2022 48.15% HC Wainwright & Co. 6 美元 → 2 美元 維護 購買
03/07/2022 270.37% 湖街 → 5 美元 啓動覆蓋範圍開啓 → 購買
11/23/2021 344.44% HC Wainwright & Co. → 6 美元 啓動覆蓋範圍開啓 → 購買
07/01/2021 418.52% 北國資本市場 → 7 美元 啓動覆蓋範圍開啓 → 跑贏大盤

Biotricity Questions & Answers

生物學問題與解答

What is the target price for Biotricity (BTCY)?
Biotricity(BTCY)的目標價格是多少?

The latest price target for Biotricity (NASDAQ: BTCY) was reported by HC Wainwright & Co. on July 15, 2022. The analyst firm set a price target for $2.00 expecting BTCY to rise to within 12 months (a possible 48.15% upside). 3 analyst firms have reported ratings in the last year.

HC Wainwright & Co. 於2022年7月15日公佈了Biotricity(納斯達克股票代碼:BTCY)的最新目標股價。該分析公司將目標股價設定爲2.00美元,預計BTCY將在12個月內上漲至2.00美元(可能上漲48.15%)。去年有3家分析公司公佈了評級。

What is the most recent analyst rating for Biotricity (BTCY)?
Biotricity(BTCY)的最新分析師評級是多少?

The latest analyst rating for Biotricity (NASDAQ: BTCY) was provided by HC Wainwright & Co., and Biotricity maintained their buy rating.

Biotricity(納斯達克股票代碼:BTCY)的最新分析師評級由HC Wainwright & Co. 提供,Biotricity維持買入評級。

When is the next analyst rating going to be posted or updated for Biotricity (BTCY)?
Biotricity(BTCY)的下一個分析師評級何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biotricity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biotricity was filed on July 15, 2022 so you should expect the next rating to be made available sometime around July 15, 2023.

分析師在進行了廣泛的研究後得出了股票評級,其中包括瀏覽公開財務報表,與Biotricity的高管和客戶交談,以及聽取業績電話會議。大多數分析師每三個月進行一次評級,因此每家公司每年應獲得4個評級。Biotricity的最後一次評級是在2022年7月15日提交的,因此您應該預計下一個評級將在2023年7月15日左右公佈。

Is the Analyst Rating Biotricity (BTCY) correct?
分析師對 Biotricity (BTCY) 的評級是否正確?

While ratings are subjective and will change, the latest Biotricity (BTCY) rating was a maintained with a price target of $6.00 to $2.00. The current price Biotricity (BTCY) is trading at is $1.35, which is out of the analyst's predicted range.

儘管評級是主觀的,並將發生變化,但最新的Biotricity(BTCY)評級維持不變,目標股價爲6.00美元至2.00美元。Biotricity(BTCY)目前的交易價格爲1.35美元,超出了分析師的預測區間。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論